UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is chronic hepatitis B being undertreated in the United States?

Journal of viral hepatitis, 2011-06, Vol.18 (6), p.377-383

2011

Volltextzugriff (PDF)

Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B

Alimentary Pharmacology and Therapeutics, 2007-11, Vol.26 (10), p.1419-1428

2007

Volltextzugriff (PDF)

Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients

Journal of viral hepatitis, 2005-01, Vol.12 (1), p.67-73

2005

Volltextzugriff (PDF)

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease : a randomized, placebo-controlled trial

AIDS (London), 2001-09, Vol.15 (13), p.1695-1700

2001

Volltextzugriff (PDF)

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

The New England journal of medicine, 2003-02, Vol.348 (9), p.800-807

2003

Volltextzugriff (PDF)

Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS

The Journal of infectious diseases, 1993-06, Vol.167 (6), p.1459-1463

1993

Volltextzugriff (PDF)

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Gastroenterology (New York, N.Y. 1943), 2004-06, Vol.126 (7), p.1750-1758

2004

Volltextzugriff (PDF)

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

The New England journal of medicine, 2005-06, Vol.352 (26), p.2673-2681

2005

Volltextzugriff (PDF)

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

Gastroenterology (New York, N.Y. 1943), 2004-01, Vol.126 (1), p.81-90

2004

Volltextzugriff (PDF)

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 2004-01, Vol.126 (1), p.91-101

2004

Volltextzugriff (PDF)

Clinical Experience and Choice of Drug Therapy for Human Immunodeficiency Virus Disease

Clinical infectious diseases, 1999-01, Vol.28 (1), p.14-22

1999

Volltextzugriff (PDF)

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response

Journal of acquired immune deficiency syndromes (1999), 2000-03, Vol.23 (3), p.221

2000

Volltextzugriff (PDF)

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

Journal of hepatology, 2003-12, Vol.39 (6), p.1085-1089

2003

Volltextzugriff (PDF)

A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals

AIDS (London), 1998-02, Vol.12 (3), p.269-277

1998

Volltextzugriff (PDF)

Reduction in Liver Transplant Wait-Listing in the Era of Direct Acting Anti-Viral Therapy

Hepatology (Baltimore, Md.), 2016-12, Vol.65 (3), p.804-812

2016

Volltextzugriff (PDF)

Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies

Kidney international, 2004-09, Vol.66 (3), p.1153-1158

2004

Volltextzugriff (PDF)

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B

Hepatology (Baltimore, Md.), 2003-07, Vol.38 (1), p.96-103

2003

Volltextzugriff (PDF)

Is chronic hepatitis B being undertreated in the United States?: Is CHB being undertreated in the US?

Journal of viral hepatitis, 2011-06, Vol.18 (6), p.377-383

2011

Volltextzugriff (PDF)

Off-label drug use in human immunodeficiency virus disease

Journal of acquired immune deficiency syndromes and human retrovirology, 1996-05, Vol.12 (1), p.56-62

1996

Volltextzugriff (PDF)

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients

AIDS (London), 2002-02, Vol.16 (3), p.387-396

2002

Volltextzugriff (PDF)

P1202 THE PHARMACOKINETICS (PK) AND SAFETY OF A SINGLE DOSE OF ADEFOVIR DIPIVOXIL (ADV) IN CHILDREN AND ADOLESCENTS (AGED 2–17) WITH CHRONIC HEPATITIS B

Journal of pediatric gastroenterology and nutrition, 2004-08, Vol.39 (2), p.226-227

2004

Volltextzugriff (PDF)

P1202 THE PHARMACOKINETICS (PK) AND SAFETY OF A SINGLE DOSE OF ADEFOVIR DIPIVOXIL (ADV) IN CHILDREN AND ADOLESCENTS (AGED 2–17) WITH CHRONIC HEPATITIS B

Journal of pediatric gastroenterology and nutrition, 2004-08, Vol.39 (2), p.226-227

2004

Volltextzugriff (PDF)

Clinical experience and choice of drug therapy for human immunodeficiency virus disease. Author's reply

Clinical infectious diseases, 1999, Vol.28 (1), p.14-25

1999

Volltextzugriff (PDF)

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy

Antiviral therapy, 2002-03, Vol.7 (1), p.43-51

2002

Volltextzugriff (PDF)

A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS

AIDS (London), 1998-02, Vol.12 (3), p.269

1998

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(29)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Infectious Diseases
(23)
Male
(23)
Adenine - Analogs & Derivatives
(21)
Female
(21)
Adult
(20)
Hepatitis B, Chronic - Drug Therapy
(18)
Adenine - Therapeutic Use
(17)
Middle Aged
(17)
Antiviral Agents - Therapeutic Use
(16)
Organophosphonates
(15)
Viral Diseases
(15)
Gastroenterology & Hepatology
(14)
Hepatitis B Virus - Genetics
(14)
Human Viral Diseases
(14)
Double-Blind Method
(12)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

9 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is chronic hepatitis B being undertreated in the United States?

Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B

Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease : a randomized, placebo-controlled trial

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B

Clinical Experience and Choice of Drug Therapy for Human Immunodeficiency Virus Disease

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals

Reduction in Liver Transplant Wait-Listing in the Era of Direct Acting Anti-Viral Therapy

Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B

Is chronic hepatitis B being undertreated in the United States?: Is CHB being undertreated in the US?

Off-label drug use in human immunodeficiency virus disease

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients

P1202 THE PHARMACOKINETICS (PK) AND SAFETY OF A SINGLE DOSE OF ADEFOVIR DIPIVOXIL (ADV) IN CHILDREN AND ADOLESCENTS (AGED 2–17) WITH CHRONIC HEPATITIS B

P1202 THE PHARMACOKINETICS (PK) AND SAFETY OF A SINGLE DOSE OF ADEFOVIR DIPIVOXIL (ADV) IN CHILDREN AND ADOLESCENTS (AGED 2–17) WITH CHRONIC HEPATITIS B

Clinical experience and choice of drug therapy for human immunodeficiency virus disease. Author's reply

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy

A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS

Suchergebnisse filtern